TRAF3 and Miyoshi myopathy: Co-occurrences, or oncogenic dependencies between genomic markers in MM, are common, including t(11;14) and mutations in CCND1 (which is also associated with recurrent interferon regulatory factor 4 (IRF4) K123R mutations), the gain of 1q and t(4;14), t(4;14) and TRAF3 deletion, and FAM46C and CDKN2C deletions, among others [20,27,28].